OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
mRNA vaccines in the prevention and treatment of diseases
Yangzhuo Gu, Jiangyao Duan, Na Yang, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 33
Yangzhuo Gu, Jiangyao Duan, Na Yang, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 33
Showing 26-50 of 33 citing articles:
In Vitro Assessment of Protamine Toxicity with Neural Cells, Its Therapeutic Potential to Counter Chondroitin Sulfate Mediated Neuron Inhibition, and Its Effects on Reactive Astrocytes
Derek W. Nelson, Jessica L. Funnell, Conrad H. Cheung, et al.
Advanced Therapeutics (2024) Vol. 7, Iss. 2
Closed Access
Derek W. Nelson, Jessica L. Funnell, Conrad H. Cheung, et al.
Advanced Therapeutics (2024) Vol. 7, Iss. 2
Closed Access
Humoral Response Following 3 Doses of mRNA COVID-19 Vaccines in Patients With Non-Dialysis-Dependent CKD: An Observational Study
Omosomi Enilama, Kevin Yau, Lee Er, et al.
Canadian Journal of Kidney Health and Disease (2024) Vol. 11
Open Access
Omosomi Enilama, Kevin Yau, Lee Er, et al.
Canadian Journal of Kidney Health and Disease (2024) Vol. 11
Open Access
Promising mRNA vaccine technology in combating infectious disease: a boon to futuristic game changer in medical science
Lalit Kumar Gautam, R. Shukla
The Applied Biology & Chemistry Journal (2024), pp. 1-3
Open Access
Lalit Kumar Gautam, R. Shukla
The Applied Biology & Chemistry Journal (2024), pp. 1-3
Open Access
Recent progress, challenges (stability and in vivo distribution), and opportunities of DNA & mRNA vaccine in cancer immunotherapy
Monika Kaushik, Prathap Madeswara Guptha, Murugesan Vanangamudi, et al.
Advances in immunology (2024)
Closed Access
Monika Kaushik, Prathap Madeswara Guptha, Murugesan Vanangamudi, et al.
Advances in immunology (2024)
Closed Access
Redefining Vaccines: Nucleic Acid Vaccines Encoding Short Therapeutic Peptides
Zhen Yun Siew, Pooi Pooi Leong, Wong Siew Tung, et al.
(2024)
Closed Access
Zhen Yun Siew, Pooi Pooi Leong, Wong Siew Tung, et al.
(2024)
Closed Access
Synthesis of Natural and Sugar-Modified Nucleosides Using the Iodine/Triethylsilane System as N-Glycosidation Promoter
Martina Cimafonte, Anna Esposito, Maria De Fenza, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 9030-9030
Open Access
Martina Cimafonte, Anna Esposito, Maria De Fenza, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 9030-9030
Open Access
The Dawning of a New Enterprise: RNA Therapeutics for the Skin
Rachel E. Kieser, Shaheerah Khan, Nada Bejar, et al.
(2023)
Open Access | Times Cited: 1
Rachel E. Kieser, Shaheerah Khan, Nada Bejar, et al.
(2023)
Open Access | Times Cited: 1
Lyophilization process optimization and molecular dynamics simulation of mRNA-LNPs for SARS-CoV-2 vaccine
Peng Yu, Mingyuan Li, Lin Jia, et al.
Research Square (Research Square) (2023)
Open Access
Peng Yu, Mingyuan Li, Lin Jia, et al.
Research Square (Research Square) (2023)
Open Access
Advances in tumor immunotherapy and gene therapy
Zhiyao He, Min Luo, Li Yang, et al.
Scientia Sinica Vitae (2022)
Closed Access
Zhiyao He, Min Luo, Li Yang, et al.
Scientia Sinica Vitae (2022)
Closed Access
A Binary RNA and DNA Self-Amplifying Platform for Next Generation Vaccines and Therapeutics
Wilfred A. Jefferies, Kyung Bok Choi, Paolo Ribeca, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Wilfred A. Jefferies, Kyung Bok Choi, Paolo Ribeca, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
